2622 Results

People

  1. Reuter
    Reuter
  2. Fong
    Fong
  3. Motzer
    Motzer
  4. Brennan
    Brennan
  5. Akin
    Akin
  6. Eastham
    Eastham
  7. Fine
    Fine
  8. Rusch
    Rusch
  9. Abrey
    Abrey
  10. Gonen
    Gonen

Groups

  1. Department of Medicine (744)
  2. Surgery (660)
  3. Sloan Kettering Institute Faculty (490)
  4. GSK Faculty (474)
  5. Solid Tumor Oncology Division (435)
  6. Survivorship Research (381)
  7. Department of Pathology and Laboratory Medicine (272)
  8. Molecular Pharmacology and Chemistry Program Faculty (271)
  9. Population Sciences Research Program (269)
  10. Radiology, Department of (237)
  1. "2007"
Formats
  1. Journal Article (1654)
  2. Meeting Abstract (774)
  3. Book Section (162)
  4. Conference Paper (22)
  5. Book Whole (10)
Groups
  1. Department of Medicine (744)
  2. Surgery (660)
  3. Sloan Kettering Institute Faculty (490)
  4. GSK Faculty (474)
  5. Solid Tumor Oncology Division (435)
  6. Survivorship Research (381)

More Groups

People
  1. Peter Scardino (58)
  2. Victor Reuter (53)
  3. Yuman Fong (50)
  4. Oguz Akin (48)
  5. Robert Motzer (48)
  6. Murray Brennan (46)

More People

Years
  1. 2007 (2622)
Publications
  1. Journal of Clinical Oncology (228)
  2. Blood (75)
  3. Annals of Surgical Oncology (71)
  4. International Journal of Radiation Oncology, Biology, Physics (61)
  5. Modern Pathology (56)
  6. Laboratory Investigation (53)

More Publications

Publishers
  1. Elsevier Inc. (279)
  2. American Society of Clinical Oncology (229)
  3. Springer (187)
  4. Nature Publishing Group (152)
  5. American Association for Cancer Research (131)
  6. Elsevier Science, Inc. (126)

More Publishers

Results (2622)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A randomized phase II trial of concurrent temozolomide (TMZ) and radiotherapy (RT) followed by dose dense compared to metronomic TMZ and maintenance cis-retinoic acid for patients with newly diagnosed glioblastoma multiforme (GBM)
    Meeting Abstract

    Sul, J.; Panageas, K. S.; Lassman, A. B.; Hormigo, A.; Nolan, C.; Gavrilovic, I. T.; Grimm, S. A.; DeAngelis, L. M.; Abrey, L. E.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • Reporting of clinical trial data: Are we fully utilizing the current clinical trial data to help manage the older adult cancer population?
    Meeting Abstract

    Tam-McDevitt, J. T.; Tew, W.; Klapper, S.; Hauser, R.; Lichtman, S.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • VEGF-Trap for patients (pts) with recurrent platinum-resistant epithelial ovarian cancer (EOC): Preliminary results of a randomized, multicenter phase II study
    Meeting Abstract

    Tew, W. P.; Colombo, N.; Ray-Coquard, I.; Oza, A.; del Campo, J.; Scambia, G.; Spriggs, D.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • Absorption profile, safety, and tolerability of a 200 µg dose of fentanyl buccal tablet (FBT) in opioid-tolerant cancer patients with or without oral mucositis
    Meeting Abstract

    Shaiova, L.; Jiang, J. G.; Darwish, M.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • VEGF-Trap (V-T) overcomes defects in dendritic cell (DC) differentiation without improvement in antigen-specific immune responses
    Meeting Abstract

    Sosman, J. A.; Fricke, I.; Mirza, N.; Dupont, J.; Lockhart, A. C.; Jackson, A.; LaFleur, B.; Gabrilovich, D.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • Phase I evaluation of carfilzomib (PR-171) in hematological malignancies: Responses in multiple myeloma and Waldenstrom's macroglobulinemia at well-tolerated doses
    Meeting Abstract

    Stewart, K. A.; O'Connor, O. A.; Alsina, M.; Trudel, S.; Urquilla, P. R.; Vallone, M. K.; Molineaux, C. J.; Goy, A.; Orlowski, R. Z.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • Sociodemographic factors influencing Breslow thickness at diagnosis for patients with melanoma
    Meeting Abstract

    Stitzenberg, K. B.; Thomas, N. E.; Berwick, M.; Anton-Culver, H.; Mujumdar, U. J.; Millikan, R. C.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • Predictors of a true complete response in colorectal liver metastases that disappear radiographically following chemotherapy
    Meeting Abstract

    Taylor, R. A.; White, R. R.; Kemeny, N.; Jarnagin, W. R.; DeMatteo, R. P.; Fong, Y.; Blumgart, L. H.; D'Angelica, M.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • Phase I study of a novel capecitabine schedule based on Norton-Simon mathematical modeling
    Meeting Abstract

    Theodoulou, M.; Traina, T. A.; Dugan, U.; Lake, D.; Fornier, M.; Feigin, K.; Patil, S.; Edwards, C.; Norton, L.; Hudis, C. A.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • Phase II trial of single-agent cetuximab in patients with persistent or recurrent epithelial ovarian or primary peritoneal carcinoma with the potential for dose escalation to rash
    Meeting Abstract

    Schilder, R. J.; Lokshin, A. E.; Holloway, R. W.; Alvarez, R. D.; Pathak, H.; Aghajanian, C.; Drescher, C. W.; Godwin, A. K.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save